As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development #CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today.
Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.
|
|
|
5,001-10,000 employees
View all Covance employees
|
|
Research
|
|
206 Carnegie Center Dr, Princeton, New Jersey 08540, US
|
|
1996
|
|
Pharmacovigilance, Cro, Clinical Trials, Biotech, Pediatrics, Life Sciences, Pharmaceuticals, Market Access, Clinical Research, Oncology, Inflammation, Commercialization, Drug Testing, Infectious Diseases, Bioanalysis, Biologics, Rare Disease, Crop Protection, Kidney Disease, Cardiovascular, Orphan Drugs, Bioassays, Immuno-Oncology, Drug Development Services, Nash, Cell And Gene Therapy, Central Laboratory Services, Clinical Trial Management Services, Toxicology Services, Small Molecule, Phase I-Iia, Phase Ii-Iii, Preclinical Solutions, Cl
|
Elissa Hahn is the CEO of Covance. To contact Elissa Hahn email at [email protected].
The decision makers in Covance are Greg Hall, Herman Scholtz, Honggang Bi, etc. Click to Find Covance decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.